Sunday, 22 May 2022

AliveCor's KardiaMobile gets NICE nod to monitor irregular heart rhythm symptoms

13 January 2022 | News

KardiaMobile would be prescribed by a healthcare professional for people experiencing arrhythmia symptoms more than 24 hours apart

AliveCor, a global leader in FDA-cleared personal electrocardiogram (ECG) technology, announced that the National Institute for Health and Care Excellence (NICE) has issued Medical Technologies Guidance (MTG) recommending KardiaMobile as an option for detecting atrial fibrillation (AF) for people with suspected paroxysmal AF, who present with symptoms such as palpitations and are referred for ambulatory ECG monitoring by a clinician.

KardiaMobile is the first personal ECG to be recommended by NICE for use within the National Health Service (NHS) in England and Wales. KardiaMobile would be prescribed by a healthcare professional for people experiencing arrhythmia (irregular heart rhythm) symptoms more than 24 hours apart. The instructions for use state that all interpretations of ECG recordings are reviewed by a healthcare professional and used to support clinical decision making.

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account